| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.24 | 7e-10 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.0009 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |